We have shown that the expression of Bmi-1 is closely associated with advanced stage and lymph node metastatic status of esophageal cancer patients, which is strongly suggesting that Bmi-1 can be used as a marker to identify subsets of ESCC cancer patients with more aggressive feature. This evidence concerns the gene BMI1 and cancer.